IntegenX
Latest round
- Series C
Last raised
- Dec 2012
Total raised
- $92M
Investors
- 9
About IntegenX
IntegenX Inc.Founded in 2003, IntegenX Inc. is based in Pleasanton, US, and focuses on advanced DNA profiling solutions. The company underwent a significant change in its operations when it was acquired by Thermo Fisher Scientific Inc. on March 16, 2018, for USD 65 mn.IntegenX Inc. offers innovative forensic DNA profiling solutions primarily through the Applied Biosystems RapidHIT ID System, known for generating forensic DNA profiles in approximately 90 minutes. This compact system is widely utilized by law enforcement, crime laboratories, and medical examiner offices to facilitate quick investigations.IntegenX Inc. operates with a transactional revenue model, focusing on direct sales to law enforcement and forensic laboratories. Their core products, including the Rapid DNA systems, are complemented by services such as training and technical support.Following its acquisition by Thermo Fisher Scientific Inc. in March 2018, IntegenX Inc. is poised for further growth by leveraging Thermo Fisher's resources. The company is expected to enhance its product offerings and targets expanding its market presence in North America, Europe, and Asia.
Who invested in IntegenX
9 investors across 6 rounds
See all investors in IntegenX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about IntegenX
Who invested in IntegenX?
IntegenX has 9 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has IntegenX raised?
IntegenX has raised 6 venture rounds. Sign up free to see how much each round raised and the total.
When did IntegenX last raise money?
IntegenX's most recent round on record is a Series C, in Dec 2012.
What does IntegenX do?
IntegenX is a biotechnology company.
Where is IntegenX headquartered?
IntegenX is headquartered in Pleasanton, US.
Which VCs invest in companies like IntegenX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at IntegenX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like IntegenX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.